| |
|
CLINICAL INFORMATION |
|
|
|
|
|
|
|
|
|
|
| |
Publications
Compiled by Dr. Jose Pereira
|
| |
Psychostimulants
- Vigano A, Watanabe S, Bruera E.
Case report: Methylphenidate for the management of depressive
disorders in terminal cancer patients. J Pain & Symptom
Manage 1995; 10(2):167-170.
- Breitbart W., Bruera E, Chochinov
H, Lynch M. A national Cancer Institute of Canada Workshop
on symptom control and supportive care in patients with
advanced cancer: methodological and administrative issues.
Neuropsychiatirc syndromes and psychological symptom in
patients with advanced cancer. J Pain & Symptom Manage 1995:
10(2):131-41.
- Bruera E, Watanabe S. Psychostimulants
as adjuvant analgesics. J Pain & Symptom manage 1994; 9(6):412-5.
- Bruera E, Fainsinger R, MacEachern
T, Hanson J. The use of methylphenidate in patients with
incident cancer pain receiving regular opiates. A preliminary
report. Pain 1992; 50:75-77.
- Bruera E, Ripamonti C. Adjuvants
to opioid analgesics. In: R. Patt (Ed) Cancer Pain, Philadelphia,
PA, JB Lippincott Co. 1992:142-59.
- Bruera E. Update on adjuvant drugs
in patients with cancer. In: Bond MR, Charlton JE, Woolf
CJ, eds. Proceedings World Congress on Pain. New York, Elsevier
Science Publications BV, 1991; 57:459-465.
- Bruera E, Miller MJ, Macmillan
K, Kuehn N. Neuropsychological effects of methylphenidate
in patients receiving a continuous infusion of narcotics
for cancer pain. Pain 1992; 48:163-66.
- Bruera E, Brenneis C, Chadwick
S, Hanson J, MacDonald RN. Methylphenidate associated with
narcotics for the treatment of cancer pain. Cancer Treat
Rep 1987; 71(1):67-70.
|
|
|
|
|
|
